A legal team headed up by Pomerantz LLP will receive a $5.5 million fee for its work representing investors in Medicare Advantage insurance provider Clover Health Investments Corp., alleging the company concealed a U.S. Department of Justice investigation it faced in the lead-up to its go-public merger with a special purpose acquisition company.